Fuso Chemical (4368) Q3 2026 earnings summary

Executive summary

• Net sales for the nine months ended December 31, 2025, rose 10.5% year-over-year to ¥57,928 million, with operating profit up 15.6% to ¥14,563 million and profit attributable to owners of parent up 16.6% to ¥10,689 million.

• Comprehensive income increased 19.8% year-over-year to ¥11,854 million for the nine-month period.

Financial highlights

• Gross profit for the nine months ended December 31, 2025, was ¥22,319 million, up from ¥19,977 million year-over-year.

• Operating profit before depreciation and amortization reached ¥21,912 million for the nine months, up from ¥18,250 million year-over-year.

• Earnings per share for the nine months ended December 31, 2025, was ¥303.14, compared to ¥260.10 in the prior year.

• Total assets as of December 31, 2025, were ¥149,422 million, with net assets at ¥113,142 million and an equity ratio of 75.7%.

Outlook and guidance

• Full-year forecast for the year ending March 31, 2026, projects net sales of ¥75,500 million (up 8.6% year-over-year), operating profit of ¥17,500 million (up 7.8%), and profit attributable to owners of parent of ¥12,200 million (up 6.3%).

• Full-year earnings per share forecast is ¥346.04.

• No revisions to the previously announced financial results or dividend forecasts.